Pharmaceutical Technology on MSN
Takeda to seek approval of plaque psoriasis pill on Phase III trial data
Zasocitinib is also being evaluated in a head-to-head study against Bristol Myers Squibb’s Sotyktu (deucravacitinib) in ...
The festive season is a time for giving, and this year members of the Protective Services Group (PSG) within the Queensland ...
The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...
Sentact has expanded its patient safety portfolio with the acquisitions of Performance Health Partners (PHP) and the Vizient Patient Safety Organization (PSO). The move aims to support Sentact’s ...
Ukraine ended 2025 without Russian gas transit. Despite predictions of disaster, the country maintained balance thanks to ...
On behalf of my family, I thank each of you, not as institutions, but as people, for the empathy, respect, and sense of duty ...
The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...
In a historic event, President Droupadi Murmu undertook a sortie aboard the indigenous submarine INS Vagsheer at the Karwar ...
Tarique Rahman said, “On behalf of my family, I thank each of you, not as institutions, but as people, for the empathy, respect, and sense of duty you showed at a time when we were grieving a great ...
Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1The decision is supported by the ...
Acquisitions strengthen Sentact’s safety solutions with industry-leading incident reporting technology and one of the nation’s largest patient safety organizations NASHVILLE, Tenn.--(BUSINESS ...
The licensed payment platform introduced Rah e Raast to enable real time QR payments at the point of delivery as it completes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results